GERN
Geron Corp
Price:  
1.26 
USD
Volume:  
5,290,996.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-243.2%
Upside

As of 2025-11-01, the EV/EBITDA ratio of Geron Corp (GERN) is -11.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 845.16 mil USD. GERN's TTM EBITDA according to its financial statements is -76.54 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.8x - 15.1x 12.0x
Forward P/E multiples 13.7x - 20.4x 17.0x
Fair Price (1.71) - (1.88) (1.80)
Upside -235.6% - -248.9% -243.2%
1.26 USD
Stock Price
(1.80) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-10-29 -10.79
2025-10-28 -11.21
2025-10-27 -11.21
2025-10-24 -10.87
2025-10-23 -10.71
2025-10-22 -10.87
2025-10-21 -11.12
2025-10-20 -11.12
2025-10-17 -10.54
2025-10-16 -10.79
2025-10-15 -11.21
2025-10-14 -10.87
2025-10-13 -11.12
2025-10-10 -11.46
2025-10-09 -12.13
2025-10-08 -12.04
2025-10-07 -11.29
2025-10-06 -11.21
2025-10-03 -11.79
2025-10-02 -12.04
2025-10-01 -12.29
2025-09-30 -11.96
2025-09-29 -11.46
2025-09-26 -11.29
2025-09-25 -11.12
2025-09-24 -11.62
2025-09-23 -11.71
2025-09-22 -11.62
2025-09-19 -11.54
2025-09-18 -11.54
2025-09-17 -11.12
2025-09-16 -10.96
2025-09-15 -11.12
2025-09-12 -11.12
2025-09-11 -11.54
2025-09-10 -11.29
2025-09-09 -11.88
2025-09-08 -11.96
2025-09-05 -12.21
2025-09-04 -12.04
2025-09-03 -12.21
2025-09-02 -12.79
2025-08-29 -12.21
2025-08-28 -12.46
2025-08-27 -12.29
2025-08-26 -12.71
2025-08-25 -12.38
2025-08-22 -12.71
2025-08-21 -12.46
2025-08-20 -12.13